Gene · 1718
Papers1,464
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,464
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-cancer analysis reveals the potential role of DHCR24 in bladder cancer via interactions with HRAS to facilitate cholesterol synthesis. | Oncol Lett | 2025 | 40535103 | PubTator, text mining | PubMed |
| The role of 7-dehydrocholesterol in inducing ER stress and apoptosis of head and neck squamous cell carcinoma. | Cancer Lett | 2025 | 40456399 | PubTator, text mining | PubMed |
| Identification of Fatty Acid Metabolism Disorder-Related Gene Signature in Septic Cardiomyopathy. | J Inflamm Res | 2025 | 40406682 | PubTator, text mining | PubMed |
| Proteome-Wide Covalent Targeting of Acidic Residues with Tunable N-Aryl Aziridines. | J Am Chem Soc | 2025 | 40343844 | PubTator, text mining | PubMed |
| Lipin1-dependent transcriptional inactivation of SREBPs contributes to selinexor sensitivity in multiple myeloma. | Acta Pharmacol Sin | 2025 | 40229499 | PubTator, text mining | PubMed |
| 3β-hydroxysteroid-Δ24 reductase integrates cholesterol metabolism and innate immune to promote PRRSV replication. | Int J Biol Macromol | 2025 | 40203946 | PubTator, text mining | PubMed |
| Identification of a novel variant (c.1-111A>G) located in GATA-1 motif of RHCE proximal promoter in two Chinese patients with the rare D-- phenotype. | Transfusion | 2025 | 40121670 | PubTator, text mining | PubMed |
| GDF15 promotes the resistance of epithelial ovarian cancer cells to gemcitabine via DHCR24-mediated cholesterol metabolism to elevate ABCB1 and ABCC1 levels in lipid rafts. | Am J Cancer Res | 2025 | 40084368 | PubTator, text mining | PubMed |
| Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway. | Front Biosci (Landmark Ed) | 2025 | 39862102 | PubTator, text mining | PubMed |
| Fatty acid metabolism-related signature suggests an oncogenic role of TEKT1 in endometrial cancer. | Taiwan J Obstet Gynecol | 2025 | 39794059 | PubTator, text mining | PubMed |
| RHCE genotyping using next generation sequencing: Allele specific reference sequences. | Transfusion | 2025 | 39710624 | PubTator, text mining | PubMed |
| Human umbilical cord mesenchymal stem cells small extracellular vesicles-derived miR-370-3p inhibits cervical precancerous lesions by targeting DHCR24. | Stem Cells Transl Med | 2025 | 39552565 | PubTator, text mining | PubMed |
| Integrating multiomics sequencing analyses uncover the key mechanisms related to oxidative stress, mitochondria, and immune cells in keloid. | Gene | 2025 | 39489224 | PubTator, text mining | PubMed |
| 24-Dehydrocholesterol Reductase Facilitates Cisplatin Resistance of Non-small Cell Lung Cancer via Repressing Reactive Oxygen Species/Ferroptosis Pathway. | Iran J Pharm Res | 2024 | 39830660 | PubTator, text mining | PubMed |
| Marine cosmetics and the blue bioeconomy: From sourcing to success stories. | iScience | 2024 | 39650733 | PubTator, text mining | PubMed |
| Interaction Between DHCR24 and hsa_circ_0015335 Facilitates Cognitive Impairment in Cerebral Small Vessel Disease Patients. | CNS Neurosci Ther | 2024 | 39578712 | PubTator, text mining | PubMed |
| Longitudinal association of peripheral blood DNA methylation with liver fat content: distinguishing between predictors and biomarkers. | Lipids Health Dis | 2024 | 39334355 | PubTator, text mining | PubMed |
| Knockouts of CYP51A1, DHCR24, or SC5D from cholesterol synthesis reveal pathways modulated by sterol intermediates. | iScience | 2024 | 39262789 | PubTator, text mining | PubMed |
| [Molecular study of a case with variant of RHCE*ce allele in haplotype dce resulting in weakened e antigen]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39217480 | PubTator, text mining | PubMed |
| Methylglyoxal Affects the Expression of miR-125b, miR-107, and Oxidative Stress Pathway-associated Genes in the SH-SY5Y Cell Line. | Adv Pharm Bull | 2024 | 39206401 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1718/papers?page=4